Super resolution imaging of protein-protein interactions
This disclosure provides methods and compositions for detecting intramolecular and intermolecular interactions, such as protein-protein interactions. These methods detect such interactions at sub-diffraction distances, and thus are referred to as super-resolution detection and imaging methods.
1. A method of detecting an intermolecular interaction between a first target molecule and a second target molecule, the method comprising:
(a) contacting a sample comprising the first target molecule and the second target molecule with:
(i) a first conjugate comprising a first binding partner linked to a first oligonucleotide that comprises a first half-docking domain and a stability domain, wherein the first binding partner binds to the first target molecule in the sample,
(ii) a second conjugate comprising a second binding partner linked to a second oligonucleotide that comprises a second half-docking domain and a stability domain, wherein the second binding partner binds to the second target molecule in the sample, and wherein the stability domain of the first conjugate binds to the stability domain of the second conjugate, thereby bringing together the half-docking domains to form a full docking domain, and
(iii) a detectably-labeled imager strand that binds to the full docking domain, wherein the imager strand is detectable only when bound to the full docking domain; and
(b) detecting the detectably-labeled imager strand bound to the full docking domain, thereby detecting the intermolecular interaction between the first target molecule and the second target molecule in the sample.
2. The method of claim 1 , wherein the first binding partner and the second binding partner are antibodies.
3. The method of claim 1 , wherein the first binding partner and the second binding partner are antigen-binding antibody fragments.
4. The method of claim 1 , wherein the first target molecule and the second target molecule are proteins.
5. The method of claim 1 , wherein the detectably-labeled imager strand comprises a fluorescent label.
6. The method of claim 1 , wherein the first binding partner is linked to the first oligonucleotide via a streptavidin-biotin binding pair, and the second binding partner is linked to the second oligonucleotide via a streptavidin-biotin binding pair.
7. The method of claim 1 , wherein the first oligonucleotide comprises a spacer domain between the half-docking domain and the stability domain, and the second oligonucleotide comprises a spacer domain between the half-docking domain and the stability domain.
8. The method of claim 1 , wherein the half-docking domain of the first conjugate has a length of 5-15 nucleotides, and the half-docking domain of the second conjugate has a length of 5-15 nucleotides.
9. The method of claim 1 , wherein the stability domain of the first conjugate has a length of 5-50 nucleotides, and the stability domain of the second conjugate has a length of 5-50 nucleotides.
10. The method of claim 1 , wherein the detectably-labeled imager strand has a length of 10-30 nucleotides.
11. A method of detecting an intramolecular interaction on a target molecule, the method comprising:
(a) contacting a sample comprising the target molecule with:
(i) a first conjugate comprising a first binding partner linked to a first oligonucleotide that comprises a first half-docking domain and a stability domain, wherein the first binding partner binds to a first binding site on the target molecule in the sample,
(ii) a second conjugate comprising a second binding partner linked to a second oligonucleotide that comprises a second half-docking domain and a stability domain,
wherein the second binding partner binds to a second target site on the target molecule in the sample, and
wherein the stability domain of the first conjugate binds to the stability domain of the second conjugate, thereby bringing together the half-docking domains to form a full docking domain, and
(iii) a detectably-labeled imager strand that binds to the full docking domain, wherein the imager strand is detectable only when bound to the full docking domain; and
(b) detecting the detectably-labeled imager strand bound to the full docking domain, thereby detecting an intramolecular interaction on the target molecule in the sample.
12. The method of claim 11 , wherein the first binding partner and the second binding partner are antibodies.
13. The method of claim 11 , wherein the first binding partner and the second binding partner are antigen-binding antibody fragments.
14. The method of claim 11 , wherein the first binding site and the second binding site are epitopes.
15. The method of claim 11 , wherein the detectably-labeled imager strand comprises a fluorescent label.
16. The method of claim 11 , wherein the first binding partner is linked to the first oligonucleotide via a streptavidin-biotin binding pair, and the second binding partner is linked to the second oligonucleotide via a streptavidin-biotin binding pair.
17. The method of claim 11 , wherein the first oligonucleotide comprises a spacer domain between the half-docking domain and the stability domain, and the second oligonucleotide comprises a spacer domain between the half-docking domain and the stability domain.
18. The method of claim 11 , wherein the half-docking domain of the first conjugate has a length of 5-15 nucleotides, and the half-docking domain of the second conjugate has a length of 5-15 nucleotides.
19. The method of claim 11 , wherein the stability domain of the first conjugate has a length of 5-50 nucleotides, and the stability domain of the second conjugate has a length of 5-50 nucleotides.
20. The method of claim 11 , wherein the detectably-labeled imager strand has a length of 10-30 nucleotides.